Product
Advertisement
Drug Development Tools for Multiple Autoimmune Diseases: TSLP Recombinant Proteins
Thymic stromal lymphopoietin (TSLP) is an important target associated with autoimmune diseases, various allergic conditions, chronic inflammation, and cancer. To facilitate the development of drugs targeting TSLP, ACROBiosystems has developed high-quality recombinant TSLP proteins. Additionally, high-quality TSLP-R protein products are also available, comprehensively accelerating your drug development process.
About ACROBiosystems
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed for discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated to innovation to simplify and accelerate the development of new, better, and more affordable medicine.
Our way of addressing challenges in biologics development is to offer a comprehensive array of tools and solutions designed for each development phase. Starting from discovery and development and moving beyond commercialization, we strive to deliver high-quality solutions that support each step of the development process. This means bringing together innovation and technology through product development and collaborations to help our customers achieve translatable results in the clinic and beyond.
Interested in seeing more content from ACROBiosystems ?
Discover all their latest news, webinars, products and more by clicking the link below.
